CIK: 0001703031
Total reported value
$1.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | DRNAUSD | Dicerna Pharmaceuticals INC | Stock-Other | 58.64% | — | -17.92% | |
| 2 | REPL | Replimune Group INC | Stock-Other | 21.14% | — | — | |
| 3 | MRNSUSD | Marinus Pharmaceuticals INC | Stock-Other | 10.63% | — | — | |
| 4 | SLDB | Solid Biosciences Inc. | Stock-Other | 5.81% | — | — | |
| 5 | ✓ | Aptinyx INC | Stock-Other | 3.78% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | DRNAUSD | Dicerna Pharmaceuticals INC | +6.3% | -17.92% | Trim |
| 2 | REPL | Replimune Group INC | +3.9% | — | Unchanged |
| 3 | MRNSUSD | Marinus Pharmaceuticals INC | +2.2% | — | Unchanged |
| 4 | ✓ | Aptinyx INC | +0.2% | — | Unchanged |
| 5 | SLDB | Solid Biosciences Inc. | -1.5% | — | Unchanged |
| 6 | IFRX | InflaRx N.V. | — | EXIT | Sold out |